Proxy Votes Now

Home › Funds › Lincoln Financial › LVIP JPMorgan Small Cap Core Fund

LVIP JPMorgan Small Cap Core Fund proxy voting record 2025-2026

Fund family: Lincoln Financial · Filed by LINCOLN VARIABLE INSURANCE PRODUCTS TRUST (CIK 914036) · SEC series S000079876

2023-20242024-20252025-2026

“With management” uses the answer Form N-PX asks for on every vote (Item 1(l)): whether the vote went with or against management’s recommendation, read from the records of the way the fund voted, and only where the filer’s records pass the site’s consistency check: 5,170 with, 228 against, 0 abstentions (in the total, not counted as with management). Shareholder proposals: 3 FOR, 9 AGAINST, 0 abstained, by the filing’s own vote-source field.

Compared with Lincoln Financial as a whole

The same two figures as Lincoln Financial’s manager page (215,541 ballot items across 71 funds and accounts), counted the same way for this fund.

2025-2026This fundItemsLincoln FinancialItems
Voted FOR the board's own proposals (directors, pay, auditor, capital, transactions, fund matters)95.9%5,24190.8%180,929
Backed environmental and social shareholder proposals at US companiesn/a27.9%1,793

Where this fund voted differently from most Lincoln Financial funds

Each ballot item this fund voted is set against the votes of the other Lincoln Financial funds and accounts on the same item (same meeting, same proposal): “most funds” is a strict majority of at least three of them, FOR against AGAINST, WITHHOLD or ABSTAIN, with split votes and items not voted left out. Funds in one family can follow separate voting policies, for example ESG funds, sub-advised funds and funds using pass-through voting.

Voted differently from most Lincoln Financial funds on 116 items (11.9% of the 975 items where a comparison was possible).

The most lopsided family majorities first, then the largest companies, then shareholder proposals.
CompanyMeetingItemThis fundMost Lincoln Financial fundsMgmtResult
KRATOS DEFENSE & SEC SOLUTIONS, INC.2026-05-12To approve an amendment to the Company's Certificate of Incorporation to provide for officer exculpation.AgainstFOR — 8 of 8 Lincoln Financial fundsForApproved, 88.6% support
INTERDIGITAL, INC.2026-06-10Approval of bylaws amendment to allow for officer exculpation as permitted by Pennsylvania law.AgainstFOR — 7 of 7 Lincoln Financial fundsForPassed (calculated), 93.0% support
BLOOM ENERGY CORPORATION2026-05-21To approve an amendment to our Restated Certificate of Incorporation to provide for officer exculpation as permitted by Delaware law.AgainstFOR — 6 of 6 Lincoln Financial fundsForApproved, 91.1% support
ESSENT GROUP LTD2026-05-06Provide a non-binding, advisory vote on our executive compensation.AgainstFOR — 6 of 6 Lincoln Financial fundsFor—
TEREX CORPORATION2026-06-25To approve the Terex Corporation 2026 Omnibus Incentive Plan.AgainstFOR — 5 of 5 Lincoln Financial fundsForPassed (calculated), 97.6% support
PORTLAND GENERAL ELECTRIC CO2026-04-24To approve, by a non-binding vote, the compensation of the Company's named executive officers.AgainstFOR — 5 of 5 Lincoln Financial fundsFor—
CRISPR THERAPEUTICS AG2026-06-04Binding vote on maximum equity for members of the Board of Directors from the 2026 Annual General Meeting to the 2027 annual general meeting of shareholders.ForAGAINST — 5 of 5 Lincoln Financial fundsFor—
CRISPR THERAPEUTICS AG2026-06-04Transact any other business that may properly come before the 2026 Annual General Meeting or any adjournment or postponement thereof.ForAGAINST — 5 of 5 Lincoln Financial fundsForApproved, 59.8% support
SUPERNUS PHARMACEUTICALS, INC.2026-06-18To approve, on a non-binding basis, the compensation paid to our named executive officers.AgainstFOR — 5 of 5 Lincoln Financial fundsForPassed (calculated), 96.5% support
COEUR MINING, INC.2026-05-12Approval of an amendment to the Company's Certificate of Incorporation to limit the liability of certain officers as permitted by law.AgainstFOR — 4 of 4 Lincoln Financial fundsForApproved, 75.4% support
SANMINA CORPORATION2026-03-09To approve the reservation of an additional 1,200,000 shares of common stock for issuance under the 2019 Equity Incentive Plan of Sanmina Corporation.AgainstFOR — 4 of 4 Lincoln Financial fundsForPassed (calculated), 96.0% support
SANMINA CORPORATION2026-03-09To approve, on an advisory (non- binding) basis, the compensation of Sanmina Corporation's named executive officers.AgainstFOR — 4 of 4 Lincoln Financial fundsForPassed (calculated), 81.4% support
PBF ENERGY INC.2026-04-28Amendment of the 2025 Equity Incentive Plan.AgainstFOR — 4 of 4 Lincoln Financial fundsFor—
AMNEAL PHARMACEUTICALS, INC.2026-05-06Advisory vote to approve executive compensation.AgainstFOR — 4 of 4 Lincoln Financial fundsForPassed (calculated), 99.1% support
FORMFACTOR, INC.2026-05-15Amendment to FormFactor's Certificate of Incorporation to Reflect New Delaware Law Provisions Regarding Officer Exculpation.AgainstFOR — 4 of 4 Lincoln Financial fundsForApproved, 87.7% support
INSIGHT ENTERPRISES, INC.2026-05-13Advisory vote (non-binding) to approve named executive officer compensation.AgainstFOR — 4 of 4 Lincoln Financial fundsForPassed (calculated), 86.7% support
CHESAPEAKE UTILITIES CORPORATION2026-05-06Approve on an advisory non-binding basis the compensation of the Company's Named Executive Officers.AgainstFOR — 4 of 4 Lincoln Financial fundsFor—
SEACOAST BANKING CORPORATION OF FLORIDA2026-05-20Advisory (Non-binding) Vote on Compensation of Named Executive OfficersAgainstFOR — 4 of 4 Lincoln Financial fundsForApproved, 98.0% support
SIRIUSPOINT LTD.2026-05-20Approval of the SiriusPoint SharePlan.AgainstFOR — 4 of 4 Lincoln Financial fundsFor—
WARBY PARKER INC.2026-06-08Approval, on an advisory (non- binding) basis, of the compensation of the Company's named executive officers.AgainstFOR — 4 of 4 Lincoln Financial fundsForApproved, 96.0% support
CALLAWAY GOLF COMPANY2026-05-21To approve, on an advisory basis, the compensation of the Company's named executive officersAgainstFOR — 4 of 4 Lincoln Financial fundsForApproved, 93.9% support
NMI HOLDINGS, INC.2026-05-14Advisory approval of NMI Holdings, Inc.'s executive compensation.AgainstFOR — 4 of 4 Lincoln Financial fundsForApproved, 92.5% support
ATRICURE, INC.2026-05-18Advisory vote on the compensation of our named executive officers as disclosed in the proxy statement for the 2026 Annual Meeting.AgainstFOR — 4 of 4 Lincoln Financial fundsForApproved, 95.9% support
KOHL'S CORPORATION2026-05-20Management Proposal: Approve the Amended and Restated Kohl's Corporation 2024 Long-Term Compensation Plan.AgainstFOR — 4 of 4 Lincoln Financial fundsForPassed (calculated), 95.4% support
STAGWELL INC.2026-06-11Approval, on an advisory basis, of the 2025 compensation of our named executive officers.AgainstFOR — 4 of 4 Lincoln Financial fundsForApproved, 98.3% support
Show all 116
Items 26 to 116.
CompanyMeetingItemThis fundMost Lincoln Financial fundsMgmtResult
XENCOR, INC.2026-06-16Approval of the amendment to the Company's Amended and Restated 2023 Equity Incentive Plan to increase the number of authorized shares reserved for issuance thereunder by 4,000,000 shares; andForAGAINST — 4 of 4 Lincoln Financial fundsForApproved, 82.0% support
ENCORE CAPITAL GROUP, INC.2026-06-12Approval and adoption of an amendment to our Amended and Restated Certificate of Incorporation to provide for exculpation of officers.AgainstFOR — 4 of 4 Lincoln Financial fundsForApproved, 90.4% support
SONIC AUTOMOTIVE, INC.2026-04-29Approval of the Sonic Automotive, Inc. 2026 Equity Incentive Plan.AgainstFOR — 4 of 4 Lincoln Financial fundsForPassed (calculated), 95.9% support
BLUE BIRD CORPORATION2026-03-11To approve an amendment to our certificate of incorporation to provide for limitation of liability of certain officers for certain breaches of fiduciary duty as permitted under Delaware law.AgainstFOR — 4 of 4 Lincoln Financial fundsForApproved, 86.2% support
BLUE BIRD CORPORATION2026-03-11To approve the Blue Bird Corporation Amended and Restated 2015 Omnibus Equity Incentive Plan.AgainstFOR — 4 of 4 Lincoln Financial fundsForApproved, 91.2% support
STOKE THERAPEUTICS, INC.2026-06-03To approve, on an advisory basis, the compensation of the Company's named executive officers.ForAGAINST — 4 of 4 Lincoln Financial fundsForPassed (calculated), 72.9% support
SUNRUN INC.2026-05-28Advisory proposal of the compensation of our named executive officers ("Say-on-Pay").AgainstFOR — 4 of 4 Lincoln Financial fundsForApproved, 89.3% support
OCEANFIRST FINANCIAL CORP.2026-05-27Approval of the OceanFirst Financial Corp. 2026 Stock Incentive Plan.AgainstFOR — 4 of 4 Lincoln Financial fundsForPassed (calculated), 93.8% support
RYERSON HOLDING CORPORATION2026-04-30An amendment to our restated certificate of incorporation to provide for officer exculpation as permitted by Delaware Law.AgainstFOR — 4 of 4 Lincoln Financial fundsForPassed (calculated), 85.4% support
FIRST MID BANCSHARES, INC.2026-04-29An Advisory Vote on Executive CompensationAgainstFOR — 4 of 4 Lincoln Financial fundsForPassed (calculated), 97.3% support
PROPETRO HOLDING CORP.2026-05-19Approval of the Third Amended and Restated 2020 Long-Term Incentive PlanAgainstFOR — 4 of 4 Lincoln Financial fundsForPassed (calculated), 97.2% support
VISTANCE NETWORKS, INC.2026-05-07Approval of additional shares under the Company's 2019 Long-Term Incentive Plan.AgainstFOR — 4 of 4 Lincoln Financial fundsForPassed (calculated), 97.7% support
SOUTH PLAINS FINANCIAL, INC.2026-05-11To transact such other business as may properly come before the annual meeting or any adjournment(s) or postponement(s) thereof.ForAGAINST — 4 of 4 Lincoln Financial fundsFor—
MATIV HOLDINGS, INC.2026-04-30Approval of the Second Amendment to the Mativ Holdings, Inc. 2024 Equity and Incentive Plan.AgainstFOR — 4 of 4 Lincoln Financial fundsForPassed (calculated), 96.9% support
EMBECTA CORP2026-02-11Advisory vote to approve named executive officer compensationAgainstFOR — 4 of 4 Lincoln Financial fundsForApproved, 98.4% support
EMBECTA CORP2026-02-11Approval of an amendment to the Embecta 2022 Employee and Director Equity-Based Compensation PlanAgainstFOR — 4 of 4 Lincoln Financial fundsForApproved, 85.5% support
SOUTHSTATE BANK CORPORATION2026-04-15Approval, as an advisory, non- binding "say on pay" resolution, of our executive compensation;AgainstFOR — 5 of 6 Lincoln Financial fundsForApproved, 95.2% support
CORCEPT THERAPEUTICS INCORPORATED2026-05-21To approve an amendment to the Corcept Therapeutics Incorporated 2024 Incentive Award Plan to increase the number of shares available thereunder and clarify certain other language in the plan.ForAGAINST — 3 of 3 Lincoln Financial fundsForApproved, 69.0% support
Hut 8 Corp.2026-06-11To approve, on an advisory basis, the compensation of our named executive officers.ForAGAINST — 3 of 3 Lincoln Financial fundsForApproved, 54.8% support
VARONIS SYSTEMS, INC.2026-06-01To approve, on a non-binding, advisory basis, the executive compensation of our named executive officers.AgainstFOR — 3 of 3 Lincoln Financial fundsForPassed (calculated), 91.2% support
TRANSOCEAN, LTD.2026-05-22If any modifications to agenda items or proposals identified in the notice of meeting or other matters on which voting is permissible under Swiss law are properly presented at the 2026 Annual General Meeting for consideration, you instruct the independent proxy, in the absence of other specific instForAGAINST — 3 of 3 Lincoln Financial fundsFor—
EASTERN BANKSHARES, INC.2026-05-18To approve, in an advisory vote, the compensation paid to the Company's named executive officers.AgainstFOR — 3 of 3 Lincoln Financial fundsForApproved, 95.2% support
THE CHEFS' WAREHOUSE, INC.2026-05-08To approve, on a non-binding, advisory basis, the compensation of our named executive officers as disclosed in the 2026 Proxy Statement.ForAGAINST — 3 of 3 Lincoln Financial fundsForApproved, 51.0% support
MAXLINEAR, INC.2026-05-20To approve an amendment and restatement of the MaxLinear, Inc. Amended and Restated 2010 Equity Incentive Plan, including approval of a new ten-year term and an increase in the number of shares reserved thereunder by 3,204,107.ForAGAINST — 3 of 3 Lincoln Financial fundsFor—
PALOMAR HOLDINGS, INC.2026-05-21Advisory Vote to Approve Named Executive Officer Compensation ("Say-On-Pay-Vote").AgainstFOR — 3 of 3 Lincoln Financial fundsForApproved, 92.6% support
KBR, INC.2026-05-14Advisory vote to approve KBR's named executive officer compensation.AgainstFOR — 5 of 6 Lincoln Financial fundsForPassed (calculated), 96.7% support
BANC OF CALIFORNIA, INC.2026-05-06Approval of the Company's Second Amended and Restated 2018 Omnibus Stock Incentive Plan.AgainstFOR — 3 of 3 Lincoln Financial fundsForApproved, 98.1% support
FIRST BUSEY CORPORATION2026-05-20To approve the First Busey Corporation Second Amended 2020 Equity Incentive Plan.AgainstFOR — 3 of 3 Lincoln Financial fundsForApproved, 95.2% support
FIRST BUSEY CORPORATION2026-05-20To approve, in a non-binding, advisory vote, the compensation of our named executive officers, as described in the accompanying proxy statement, which is referred to as a "say-on-pay" proposal.AgainstFOR — 3 of 3 Lincoln Financial fundsForApproved, 98.1% support
UNITED PARKS & RESORTS INC.2026-06-16Approval, in a non-binding advisory vote, of the compensation paid to the named executive officers.AgainstFOR — 3 of 3 Lincoln Financial fundsForApproved, 99.0% support
PROG HOLDINGS, INC.2026-05-06Approval of a non-binding advisory resolution to approve the Company's executive compensation.AgainstFOR — 3 of 3 Lincoln Financial fundsForPassed (calculated), 92.0% support
PROG HOLDINGS, INC.2026-05-06Approval of the amendment to the PROG Holdings, Inc. Amended and Restated 2015 Equity and Incentive Plan.AgainstFOR — 3 of 3 Lincoln Financial fundsForPassed (calculated), 90.7% support
KOSMOS ENERGY LTD.2026-05-28To provide a non-binding, advisory vote to approve named executive officer compensation.AgainstFOR — 3 of 3 Lincoln Financial fundsForApproved, 97.0% support
EQUITY BANCSHARES, INC.2026-04-21Approval of the Second Amendment to the Equity Bancshares, Inc. 2022 Omnibus Equity Incentive Plan.AgainstFOR — 3 of 3 Lincoln Financial fundsForApproved, 89.6% support
ORIC PHARMACEUTICALS, INC.2026-06-18To approve the ORIC Pharmaceuticals, Inc. 2020 Equity Incentive Plan, as amended and restated.ForAGAINST — 3 of 3 Lincoln Financial fundsForApproved, 69.2% support
REGENXBIO INC.2026-05-29To approve a stock option exchange for our executive employees.ForAGAINST — 3 of 3 Lincoln Financial fundsFor—
REGENXBIO INC.2026-05-29To approve a stock option exchange for our non-executive employees.ForAGAINST — 3 of 3 Lincoln Financial fundsForApproved, 74.9% support
OIL STATES INTERNATIONAL, INC.2026-05-12TO APPROVE, ON AN ADVISORY BASIS, THE COMPANY'S EXECUTIVE COMPENSATION.AgainstFOR — 3 of 3 Lincoln Financial fundsForPassed (calculated), 93.7% support
PROTHENA CORPORATION PLC2026-05-14To approve, in a non-binding advisory vote, the compensation of the executive officers named in the Company's Proxy Statement for the Annual General Meeting.AgainstFOR — 3 of 3 Lincoln Financial fundsForApproved, 96.6% support
TECHTARGET, INC.2026-06-11To approve an advisory (non- binding) resolution to approve the compensation of our named executive officers.AgainstFOR — 3 of 3 Lincoln Financial fundsForApproved, 97.1% support
CRISPR THERAPEUTICS AG2026-06-04Binding vote on maximum equity for members of the Executive Committee from the 2026 Annual General Meeting to the 2027 annual general meeting of shareholders.ForAGAINST — 4 of 5 Lincoln Financial fundsFor—
CRISPR THERAPEUTICS AG2026-06-04Non-binding advisory vote on the 2025 Compensation Report.ForAGAINST — 4 of 5 Lincoln Financial fundsFor—
CRISPR THERAPEUTICS AG2026-06-04Non-binding advisory vote on the compensation paid to the Company's named executive officers under U.S. securities law requirements.ForAGAINST — 4 of 5 Lincoln Financial fundsForApproved, 69.4% support
CRISPR THERAPEUTICS AG2026-06-04Re-election of Simeon J. George, M.D.AgainstFOR — 4 of 5 Lincoln Financial fundsForElected, 97.5% support
SITIME CORPORATION2026-05-29To approve, on an advisory basis, the compensation of SiTime's named executive officers as disclosed in SiTime's proxy statement.ForAGAINST — 5 of 7 Lincoln Financial fundsForApproved, 82.1% support
BRIDGEBIO PHARMA, INC.2026-06-22To approve an amendment and restatement of the 2021 Amended and Restated BridgeBio Pharma, Inc. Stock Option and Incentive Plan to increase the number of shares of common stock reserved for issuance thereunder by 2,000,000 shares.ForAGAINST — 3 of 4 Lincoln Financial fundsForApproved, 82.9% support
NOBLE CORPORATION PLC2026-04-29Authorization of the Board to Allot Shares without Rights of Pre- Emption.ForAGAINST — 3 of 4 Lincoln Financial fundsForApproved, 81.0% support
NOBLE CORPORATION PLC2026-04-29Authorization of the Board to Allot Shares.ForAGAINST — 3 of 4 Lincoln Financial fundsFor—
BOX, INC.2026-06-25To approve an amendment to our Amended and Restated 2015 Equity Incentive Plan to increase the number of shares reserved for issuance by 7,200,000 shares.ForAGAINST — 3 of 4 Lincoln Financial fundsForApproved, 61.5% support
MOELIS & COMPANY2026-06-25To approve, on an advisory basis, the compensation of our Named Executive Officers.ForAGAINST — 4 of 6 Lincoln Financial fundsForApproved, 76.5% support
MARRIOTT VACATIONS WORLDWIDE CORPORATION2026-05-15Approval of the Second Amended and Restated Marriott Vacations Worldwide Corporation 2020 Equity Incentive Plan.ForAGAINST — 3 of 4 Lincoln Financial fundsForApproved, 69.0% support
PAR PACIFIC HOLDINGS, INC.2026-04-30To approve the Par Pacific Holdings, Inc. 2026 Long-Term Incentive Plan.ForAGAINST — 3 of 4 Lincoln Financial fundsForPassed (calculated), 70.6% support
KB HOME2026-04-23Advisory vote to approve named executive officer compensationAgainstFOR — 4 of 6 Lincoln Financial fundsForPassed (calculated), 87.7% support
CUSTOMERS BANCORP, INC.2026-05-26To approve a non-binding advisory resolution on named executive officer compensation.ForAGAINST — 3 of 4 Lincoln Financial fundsForPassed (calculated), 67.9% support
AMBARELLA, INC.2026-06-26To approve an amendment and restatement of the Ambarella, Inc. 2021 Equity Incentive Plan.ForAGAINST — 3 of 4 Lincoln Financial fundsFor—
A10 NETWORKS, INC.2026-04-22To approve, on an advisory and non- binding basis, the compensation of our named executive officers.ForAGAINST — 3 of 4 Lincoln Financial fundsForPassed (calculated), 73.8% support
NLIGHT, INC.2026-06-05Election of Class II Director: Geoffrey MooreForWITHHOLD — 3 of 4 Lincoln Financial fundsForPassed (calculated), 55.6% support
VERACYTE, INC.2026-06-10The approval of an amendment to our Veracyte, Inc. 2023 Equity Incentive Plan.ForAGAINST — 3 of 4 Lincoln Financial fundsForPassed (calculated), 71.2% support
NAVITAS SEMICONDUCTOR CORPORATION2026-06-25The approval of an advisory resolution on the compensation of our named executive officers.ForAGAINST — 3 of 4 Lincoln Financial fundsForApproved, 77.3% support
TRICO BANCSHARES2026-05-21Amendment to the Company's Bylaws to eliminate cumulative voting rights.ForAGAINST — 3 of 4 Lincoln Financial fundsForApproved, 65.2% support
Costamare Inc.2025-10-02Elect Director Charlotte StratosForAGAINST — 3 of 4 Lincoln Financial fundsFor—
Costamare Inc.2025-10-02Elect Director Konstantinos KonstantakopoulosForAGAINST — 3 of 4 Lincoln Financial fundsFor—
BEAZER HOMES USA, INC.2026-02-05Ratification of the Rights Agreement for the Protection of NOLs and Energy-Efficiency Tax Credits.ForAGAINST — 3 of 4 Lincoln Financial fundsForApproved, 78.8% support
FIRSTCASH HOLDINGS, INC.2026-06-09Approve the reincorporation of the Company to the State of Texas by conversion.ForAGAINST — 3 of 5 Lincoln Financial fundsForApproved, 58.4% support
FLUOR CORPORATION2026-05-06An advisory vote to approve the company's executive compensation.ForAGAINST — 3 of 5 Lincoln Financial fundsForPassed (calculated), 87.5% support
INTERNATIONAL SEAWAYS, INC.2026-06-08Ratification of the Second Amended and Restated Rights Agreement.ForAGAINST — 3 of 5 Lincoln Financial fundsFor—
CRISPR THERAPEUTICS AG2026-06-04Approval of the CRISPR Therapeutics AG 2026 Stock Option and Incentive Plan.ForAGAINST — 3 of 5 Lincoln Financial fundsForApproved, 88.1% support
CRISPR THERAPEUTICS AG2026-06-04Binding vote on maximum non- performance-related compensation for members of the Executive Committee from July 1, 2026 to June 30, 2027.ForAGAINST — 3 of 5 Lincoln Financial fundsFor—
CRISPR THERAPEUTICS AG2026-06-04Binding vote on maximum variable compensation for members of the Executive Committee for the current year ending December 31, 2026.ForAGAINST — 3 of 5 Lincoln Financial fundsFor—
POLARIS INC.2026-04-30Adoption of the Amended and Restated Polaris Inc. 2024 Omnibus Incentive PlanAgainstFOR — 3 of 5 Lincoln Financial fundsForApproved, 85.2% support
FIGS, INC.2026-06-03Approval, on an advisory (non- binding) basis, of the compensation of the Company's named executive officers.ForAGAINST — 3 of 5 Lincoln Financial fundsForApproved, 83.9% support
GLOBALSTAR, INC.2026-05-13Approve, on an advisory basis, the compensation of our named executive officers.ForAGAINST — 2 of 3 Lincoln Financial fundsForApproved, 96.4% support
TRANSOCEAN, LTD.2026-05-22Advisory Vote to Approve Named Executive Officer Compensation for Fiscal Year 2026ForAGAINST — 2 of 3 Lincoln Financial fundsForApproved, 82.7% support
SSR MINING INC.2026-05-07To approve on an advisory (non- binding) basis, the compensation of the Company's named executive officers disclosed in this Proxy Statement.AgainstFOR — 2 of 3 Lincoln Financial fundsForPassed (calculated), 54.3% support
IRIDIUM COMMUNICATIONS INC.2026-05-20Advisory vote to approve the compensation of Iridium Communications Inc.'s named executive officersAgainstFOR — 2 of 3 Lincoln Financial fundsForApproved, 86.8% support
MAXLINEAR, INC.2026-05-20To approve, on an advisory basis, the compensation of our named executive officers for the year ended December 31, 2025, as set forth in the proxy statement.ForAGAINST — 2 of 3 Lincoln Financial fundsForApproved, 85.0% support
HIMS & HERS HEALTH, INC.2026-06-11Advisory approval of the Company's executive compensation.ForAGAINST — 2 of 3 Lincoln Financial fundsForPassed (calculated), 99.3% support
WESBANCO, INC.2026-04-15To approve an advisory (non- binding) vote on compensation paid to Wesbanco's named executive officers in 2025.ForAGAINST — 2 of 3 Lincoln Financial fundsForApproved, 64.6% support
CIPHER DIGITAL INC.2026-06-02Approval, on a non-binding advisory basis, of the compensation of our named executive officers.AgainstFOR — 2 of 3 Lincoln Financial fundsForApproved, 83.5% support
PORCH GROUP, INC.2026-06-10To approve of, on an advisory (non- binding) basis, the compensation of our named executive officers.AgainstFOR — 2 of 3 Lincoln Financial fundsForApproved, 93.1% support
BEACON FINANCIAL CORPORATION2026-05-13To approve, on a non-binding advisory basis, the compensation of our named executive officers.ForAGAINST — 2 of 3 Lincoln Financial fundsForPassed (calculated), 60.1% support
BLACKLINE, INC.2026-05-07Approval, on a non-binding, advisory basis, of the 2025 compensation of the Company's named executive officers.ForAGAINST — 2 of 3 Lincoln Financial fundsForApproved, 62.4% support
INTELLIA THERAPEUTICS, INC.2026-06-09Approval, on a non-binding advisory basis, of the compensation of our named executive officers.ForAGAINST — 2 of 3 Lincoln Financial fundsFor—
NOVOCURE LIMITED2026-06-03The approval of our amended and restated 2024 Omnibus Incentive Plan.ForAGAINST — 2 of 3 Lincoln Financial fundsForApproved, 50.3% support
PUBMATIC, INC.2026-05-29To approve, on a non-binding advisory basis, the compensation of our named executive officers.ForAGAINST — 2 of 3 Lincoln Financial fundsForApproved, 96.8% support
PEAPACK-GLADSTONE FINANCIAL CORPORATION2026-04-29To approve on a non-binding basis, the compensation of the Company's named executive officers.ForAGAINST — 2 of 3 Lincoln Financial fundsForPassed (calculated), 70.3% support
SOLID BIOSCIENCES INC.2026-06-10The approval of an advisory vote on executive compensation.ForAGAINST — 2 of 3 Lincoln Financial fundsForApproved, 92.1% support
CONSOLIDATED WATER CO. LTD.2026-06-01The approval of the Company's 2027 Employee Stock Incentive Plan.ForAGAINST — 2 of 3 Lincoln Financial fundsForApproved, 75.5% support
GOGO INC.2026-05-28Advisory vote approving executive compensationForAGAINST — 2 of 3 Lincoln Financial fundsForApproved, 91.9% support
UNISYS CORPORATION2026-04-30Approve the amendment to the Unisys Corporation 2024 Long-Term Incentive and Equity Compensation Plan.AgainstFOR — 2 of 3 Lincoln Financial fundsForApproved, 81.9% support
POTLATCHDELTIC CORPORATION2026-01-27The PotlatchDeltic adjournment proposal: A proposal to adjourn the special meeting from time to time, if necessary or appropriate, to solicit additional proxies in the event there are not sufficient votes at the time of the special meeting to approve the PotlatchDeltic merger agreement proposal.ForAGAINST — 2 of 3 Lincoln Financial fundsFor—

Download all 116 differences (CSV)

Votes against management by sector

The same votes as “with management” above, by the sector of the company voted on. 95.4% of this fund’s 5,398 such votes could be given a sector; the other 246 (4.6%) are at companies without one and are not in the table.

SectorVotesAgainst managementShare
Finance1,322534.0%
Health Care884374.2%
Consumer Discretionary842384.5%
Technology494316.3%
Industrials492153.0%
Real Estate35651.4%
Energy30482.6%
Utilities17863.4%
Telecommunications9899.2%
Miscellaneous7445.4%
Basic Materials6334.8%
Consumer Staples4524.4%

What it voted on

Ballot items by the category the filing put first; “against management” as above.
Proposal typeItemsAgainst management
Director Elections3,74988
Say-on-Pay63170
Audit-related6090
Compensation18436
Corporate Governance13620
Capital Structure726
Extraordinary Transactions507
Shareholder Rights and Defenses181
Diversity, Equity, and Inclusion10
Human Rights or Human Capital/workforce10

Its largest holdings’ meetings

Position = shares voted × a recent share price, for US-listed shares of companies with a page on this site; an estimate for ranking only.

CompanyMeetingEst. positionItemsAgainst mgmt
BLOOM ENERGY CORPORATIONMay 21, 2026$2M82
MYR GROUP INC.April 23, 2026$2M100
10X GENOMICS, INC.June 4, 2026$1M50
VICTORIA'S SECRET & CO.June 11, 2026$1M110
Modine Manufacturing CompanyAugust 21, 2025$1M60
EnerSysJuly 31, 2025$1M50
API GROUP CORPORATIONMay 15, 2026$1M120
GRIFFON CORPORATIONFebruary 18, 2026$1M130

Notable votes against management

MeetingCompanyProposalFundMgmt
May 21, 2026BLOOM ENERGY CORPORATIONDIRECTOR Jeffrey ImmeltWithholdFor
May 21, 2026BLOOM ENERGY CORPORATIONTo approve an amendment to our Restated Certificate of Incorporation to provide for officer exculpation as permitted by Delaware law.AgainstFor
June 12, 2026ENCORE CAPITAL GROUP, INC.Approval and adoption of an amendment to our Amended and Restated Certificate of Incorporation to provide for exculpation of officers.AgainstFor
May 18, 2026EASTERN BANKSHARES, INC.Election of Director for a one-year term: Diane S. HessanAgainstFor
May 18, 2026EASTERN BANKSHARES, INC.To approve, in an advisory vote, the compensation paid to the Company's named executive officers.AgainstFor
March 9, 2026SANMINA CORPORATIONElection of Director: Mythili SankaranAgainstFor
March 9, 2026SANMINA CORPORATIONTo approve, on an advisory (non- binding) basis, the compensation of Sanmina Corporation's named executive officers.AgainstFor
June 10, 2026PORCH GROUP, INC.DIRECTOR Sean KellWithholdFor
June 10, 2026PORCH GROUP, INC.DIRECTOR Maurice TullochWithholdFor
June 30, 2026BRAZE, INC.To approve an amendment to our Amended and Restated Certificate of Incorporation to provide for the exculpation of officers as permitted by recent amendments to Delaware law.AgainstFor
April 29, 2026BLACK HILLS CORPORATIONDIRECTOR Scott M. ProchazkaWithholdFor
May 15, 2026FORMFACTOR, INC.Amendment to FormFactor's Certificate of Incorporation to Reflect New Delaware Law Provisions Regarding Officer Exculpation.AgainstFor

Contested meetings

Meetings with a proxy contest or competing nominees (4 in 2025-2026), and how the fund voted the items on its ballot.

Search this fund’s votes by company

5,452 ballot items at 648 meetings in 2025-2026. Download all votes (CSV)

Recent notable votes

Recent votes against management’s recommendation at large companies.

About this fund’s record

In the 2025-2026 proxy season, LVIP JPMorgan Small Cap Core Fund voted at 648 shareholder meetings of 626 companies, on 5,452 ballot items in all. On the 5,398 items where its filing records whether the vote went with or against management's recommendation, the fund voted with management on 95.8% and against it 228 times. Its most frequent area of disagreement was director elections (88 of its votes against management). It voted on 12 shareholder proposals. It voted FOR the board's own proposals more often than Lincoln Financial's funds as a whole (95.9% against 90.8%). It voted differently from most Lincoln Financial funds on 116 items. 4 of its meetings were contested.

About this page

Correction (20 November 2026): Until this date, the “votes against management” figures on /trends and on fund pages were miscounted. Form N-PX asks each fund to record whether each vote was for or against management’s recommendation; we had read that field as the recommendation itself. So a fund voting against a shareholder proposal, as the board recommended, was counted as voting against management, and a vote against a board nominee was counted as with management. Figures now use the field as the form defines it, only for filers whose records pass our consistency check; other votes show as “not determined”. Example: mega caps, 2026: 16.4% before, 8.6% now. Vanguard 500 Index: 67.2% with management before, 97.5% now.

Every figure is derived from the fund’s own Form N-PX filings with the SEC, read item by item: one ballot item is the fund’s vote on one proposal at one meeting, and an item filed twice in the season is counted once. Percentages count items, never shares. A season is published only with at least 250 ballot items at 15 meetings. Built November 20, 2026; the family figures are those of Lincoln Financial’s manager page. The interactive database shows the same votes company by company, with every other fund that voted.